Martine van Vugt
Director/Miembro de la Junta en SCANDION ONCOLOGY A/S .
Cargos activos de Martine van Vugt
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GENMAB A/S | Corporate Officer/Principal | 29/03/2023 | - |
Oficial de Recursos Humanos | 01/01/2019 | 29/03/2023 | |
SCANDION ONCOLOGY A/S | Director/Miembro de la Junta | 01/04/2022 | - |
Independent Dir/Board Member | 01/04/2022 | - | |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Director/Miembro de la Junta | - | - |
Hollandbio | Director/Miembro de la Junta | - | - |
Historial de carrera de Martine van Vugt
Antiguos cargos conocidos de Martine van Vugt.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TME PHARMA N.V. | Director/Miembro de la Junta | 24/06/2021 | 29/06/2023 |
Independent Dir/Board Member | 24/06/2021 | 29/06/2023 |
Formación de Martine van Vugt.
Wageningen University | Graduate Degree |
University of Utrecht | Doctorate Degree |
Estadísticas
Internacional
Países Bajos | 5 |
Dinamarca | 3 |
Alemania | 2 |
Operativa
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Human Resources Officer | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
GENMAB A/S | Health Technology |
TME PHARMA N.V. | Health Technology |
SCANDION ONCOLOGY A/S | Health Technology |
Empresas privadas | 2 |
---|---|
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Health Technology |
Hollandbio |
- Bolsa de valores
- Insiders
- Martine van Vugt
- Experiencia